We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Procter & Gamble, Becton, Dickinson, Dominion, Chubb and Estee Lauder
Read MoreHide Full Article
For Immediate Release
Chicago, IL –February 7, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Procter & Gamble (PG - Free Report) , Becton, Dickinson (BDX - Free Report) , Dominion Energy (D - Free Report) , Chubb (CB - Free Report) and Estee Lauder (EL - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Analyst Reports for Procter & Gamble, Becton, Dickinson & Dominion
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG - Free Report) , Becton, Dickinson (BDX - Free Report) and Dominion Energy (D - Free Report) . These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Buy-ranked Procter & Gamble’s shares have outperformed the Zacks Soap and Cleaning Materials industry in the past three months, gaining +6.7% vs +4%. The Zacks analyst thinks that this can be attributed to owing to strong second-quarter fiscal 2019 results, robust earnings trend and upbeat view for fiscal 2019. Top and bottom line beat estimates in the fiscal second quarter, marking 15th straight earnings beat and fifth sales beat in the last six quarters.
Earnings benefited from the tax reforms, while strong organic growth with higher shipment volumes and favorable price/mix boosted sales. The company raised the sales guidance for fiscal 2019. It is also gaining from focus on product improvement, packaging and marketing initiatives, and productivity and cost-savings plan.
However, it is witnessing strained margins owing to increased commodity and shipping costs, higher brand investments and aggressive pricing from private-label products amid intense competition. Moreover, adverse currency rates are hurting P&G’s results, which is likely to continue in fiscal 2019.
Shares of Becton, Dickinson have outperformed the Zacks Dental Supplies industry over the past year, gaining +9.2% vs. -3.3%. Becton Dickinson, also known as BD, exited the fiscal first quarter on a mixed note. While earnings met estimates, revenues lagged the same.
The Zacks analyst likes the solid performance of the core BD Medical and Life Sciences units. Domestic and international revenues increased year over year in the quarter. Management is optimistic about the C.R. Bard buyout which has been consistently proven accretive. Notably, a series of product launches and regulatory approvals continue to boost the stock. The company has kept its fiscal 2019 guidance intact.
However, contraction in gross and operating margins in the quarter is worrisome. Customer ordering patterns are also expected to negatively impact fiscal second-quarter results. Management expects unfavorable foreign currency to partially mar BD’s prospects in fiscal 2019. Stiff competition in the MedTech space adds to the woes.
Dominion Energy’s shares have gained +1.2% over the past six months, underperforming the Zacks Electric Power industry, which has increased +5.2% over the same period. Dominion Energy missed fourth-quarter earnings estimates due to lower renewable energy investment tax credits, higher storm restoration cost and increased interest expense.
The Zacks analyst thinks Dominion Energy is benefiting from its regulated growth projects and synergies from acquisition. The company’s expansion of electric transmission, natural gas facilities and midstream assets are strong positives. The company completed its merger with SCANA and it is likely to be immediately accretive to earnings.
However, any delay in the ongoing capital projects may impact Dominion Energy’s profitability. Moreover, increase in pension expenses and share dilution may affect future earnings. The company and its gas unit’s dependency upon third-party producers for natural gas supply increases risk.
Other noteworthy reports we are featuring today include Chubb (CB - Free Report) and Estee Lauder (EL - Free Report) .
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Procter & Gamble, Becton, Dickinson, Dominion, Chubb and Estee Lauder
For Immediate Release
Chicago, IL –February 7, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Procter & Gamble (PG - Free Report) , Becton, Dickinson (BDX - Free Report) , Dominion Energy (D - Free Report) , Chubb (CB - Free Report) and Estee Lauder (EL - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Analyst Reports for Procter & Gamble, Becton, Dickinson & Dominion
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG - Free Report) , Becton, Dickinson (BDX - Free Report) and Dominion Energy (D - Free Report) . These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Buy-ranked Procter & Gamble’s shares have outperformed the Zacks Soap and Cleaning Materials industry in the past three months, gaining +6.7% vs +4%. The Zacks analyst thinks that this can be attributed to owing to strong second-quarter fiscal 2019 results, robust earnings trend and upbeat view for fiscal 2019. Top and bottom line beat estimates in the fiscal second quarter, marking 15th straight earnings beat and fifth sales beat in the last six quarters.
Earnings benefited from the tax reforms, while strong organic growth with higher shipment volumes and favorable price/mix boosted sales. The company raised the sales guidance for fiscal 2019. It is also gaining from focus on product improvement, packaging and marketing initiatives, and productivity and cost-savings plan.
However, it is witnessing strained margins owing to increased commodity and shipping costs, higher brand investments and aggressive pricing from private-label products amid intense competition. Moreover, adverse currency rates are hurting P&G’s results, which is likely to continue in fiscal 2019.
(You can read the full research report on Procter & Gamble here >>>).
Shares of Becton, Dickinson have outperformed the Zacks Dental Supplies industry over the past year, gaining +9.2% vs. -3.3%. Becton Dickinson, also known as BD, exited the fiscal first quarter on a mixed note. While earnings met estimates, revenues lagged the same.
The Zacks analyst likes the solid performance of the core BD Medical and Life Sciences units. Domestic and international revenues increased year over year in the quarter. Management is optimistic about the C.R. Bard buyout which has been consistently proven accretive. Notably, a series of product launches and regulatory approvals continue to boost the stock. The company has kept its fiscal 2019 guidance intact.
However, contraction in gross and operating margins in the quarter is worrisome. Customer ordering patterns are also expected to negatively impact fiscal second-quarter results. Management expects unfavorable foreign currency to partially mar BD’s prospects in fiscal 2019. Stiff competition in the MedTech space adds to the woes.
(You can read the full research report on Becton, Dickinson here >>>).
Dominion Energy’s shares have gained +1.2% over the past six months, underperforming the Zacks Electric Power industry, which has increased +5.2% over the same period. Dominion Energy missed fourth-quarter earnings estimates due to lower renewable energy investment tax credits, higher storm restoration cost and increased interest expense.
The Zacks analyst thinks Dominion Energy is benefiting from its regulated growth projects and synergies from acquisition. The company’s expansion of electric transmission, natural gas facilities and midstream assets are strong positives. The company completed its merger with SCANA and it is likely to be immediately accretive to earnings.
However, any delay in the ongoing capital projects may impact Dominion Energy’s profitability. Moreover, increase in pension expenses and share dilution may affect future earnings. The company and its gas unit’s dependency upon third-party producers for natural gas supply increases risk.
(You can read the full research report on Dominion Energy here >>>).
Other noteworthy reports we are featuring today include Chubb (CB - Free Report) and Estee Lauder (EL - Free Report) .
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.